Literature DB >> 12850514

The spectrum of phenotypes in females with Rett Syndrome.

Peter Huppke1, Melanie Held, Franco Laccone, Folker Hanefeld.   

Abstract

Since the discovery of mutations in the methyl-CpG binding protein-2 (MECP2) gene in Rett Syndrome (RTT) a large number of females have been diagnosed worldwide. In this article we present the clinical and developmental data of 120 RTT females with mutations in the MECP2 gene and individually describe typical and atypical cases. We found a broad spectrum of phenotypes in females. At the severest end we have females with primary developmental delay who never learned to turn, sit or walk and who developed severe epilepsy. At the mildest end of the spectrum, there are females with only minor neurological symptoms who have good gross motor function, speak and have relatively well-preserved hand function. A number of girls either do not fulfil all the necessary diagnostic criteria or present with symptoms that have not been described in RTT before. Comparing our data with the normal population we found that girls with RTT have a smaller occipito-frontal circumference, shorter length and lower weight at birth. As a result of molecular genetic analysis a broad spectrum of phenotypes in RTT females has evolved. We found evidence that the defect in MeCP2 influences the somatic growth before birth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850514     DOI: 10.1016/s0387-7604(03)00018-4

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  Brief report: MECP2 mutations in people without Rett syndrome.

Authors:  Bernhard Suter; Diane Treadwell-Deering; Huda Y Zoghbi; Daniel G Glaze; Jeffrey L Neul
Journal:  J Autism Dev Disord       Date:  2014-03

2.  Functional outcomes in Rett syndrome.

Authors:  Frank S Pidcock; Cynthia Salorio; Genila Bibat; Jennifer Swain; Jocelyn Scheller; Wendy Shore; SakkuBai Naidu
Journal:  Brain Dev       Date:  2015-07-11       Impact factor: 1.961

3.  Very mild cases of Rett syndrome with skewed X inactivation.

Authors:  P Huppke; E M Maier; A Warnke; C Brendel; F Laccone; J Gärtner
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

4.  Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion.

Authors:  Konrad Oexle; Barbara Thamm-Mücke; Thomas Mayer; Sigrid Tinschert
Journal:  Eur J Pediatr       Date:  2004-11-19       Impact factor: 3.183

5.  InterRett, a model for international data collection in a rare genetic disorder.

Authors:  Sandra Louise; Sue Fyfe; Ami Bebbington; Nadia Bahi-Buisson; Alison Anderson; Mercé Pineda; Alan Percy; Bruria Ben Zeev; Xi Ru Wu; Xinhua Bao; Patrick Mac Leod; Judith Armstrong; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2009-07

6.  Gross motor profile in rett syndrome as determined by video analysis.

Authors:  J A Downs; A Bebbington; P Jacoby; M E Msall; O McIlroy; S Fyfe; N Bahi-Buisson; W E Kaufmann; H Leonard
Journal:  Neuropediatrics       Date:  2009-01-22       Impact factor: 1.947

7.  A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes.

Authors:  Dong Keon Yon; Ji Eun Park; Seung Jun Kim; Sung Han Shim; Kyu Young Chae
Journal:  BMC Med Genet       Date:  2017-03-17       Impact factor: 2.103

8.  Monozygotic twins with Rett syndrome: Phenotyping the first two years of life.

Authors:  Christa Einspieler; Peter B Marschik; Wanderley Domingues; Victor B Talisa; Katrin D Bartl-Pokorny; Thomas Wolin; Jeff Sigafoos
Journal:  J Dev Phys Disabil       Date:  2014-04

Review 9.  The relationship of Rett syndrome and MECP2 disorders to autism.

Authors:  Jeffrey Lorenz Neul
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

10.  Training communication abilities in Rett Syndrome through reading and writing.

Authors:  Rosa Angela Fabio; Ilaria Castelli; Antonella Marchetti; Alessandro Antonietti
Journal:  Front Psychol       Date:  2013-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.